![Tomas D. Bertmark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomas D. Bertmark
Direktor/Vorstandsmitglied bei CanImGuide Therapeutics AB
Aktive Positionen von Tomas D. Bertmark
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - |
Karriereverlauf von Tomas D. Bertmark
Statistik
International
Schweden | 2 |
Operativ
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
CanImGuide Therapeutics AB
![]() CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Börse
- Insiders
- Tomas D. Bertmark
- Erfahrung